NEW YORK, NY – (NewMediaWire) – August 12, 2020 – The Australian government has accepted Rapid Nutrition ( RAP: SW, OTCQB: RPNRF ) into its touted Entrepreneurs Programme, which shares expert advice, funding and incentives to help businesses innovate, compete and grow. A natural healthcare company focused on sports nutrition, diet management and life sciences products with extensive worldwide distribution, Rapid Nutrition continues to expand international business operations as well as local research projects.
In addition to the Entrepreneurs Programme, Rapid Nutrition recently received a government-sponsored Innovations Grant that will allow the company to increase research into a new formula intended to prevent colds and flus.
“As an entrepreneurial organization focused on business growth and innovation, we look forward to expanding our knowledge base, local connections and opportunities through the Entrepreneurs Programme,” said Rapid Nutrition CEO Simon St. Ledger. “We are proud to be a part of this flagship initiative from the Australian government.”
Rapid Nutrition aims to use recent grants and programme education to further its study on Azurene, an anti-viral resulting from several years of research, including in-vitro testing, scholarly literature and continuing clinical trials ahead of product launch. In addition to research support, the Entrepreneurs Programme offers business and supply chain facilitation and growth services, among others.
About Rapid Nutrition
Rapid Nutrition PLC(SW:RAP, OTCQB:RPNRF): Dedicating to the development and distribution of premium, science-based health and wellness brands across the globe, Rapid Nutrition shares a wealth of award-winning products with consumers who are passionate about innovations that are “made by nature, refined by science.” Rapid Nutrition’s first-class scientific team matches the experience of its management team to keep both the company and consumers on top of the latest industry trends and developments, while aligning with industry leaders worldwide to deliver effective supplements and solutions. For more information, please visit http://rnplc.com
Investor Relations Contact: email@example.com
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks, uncertainties and assumptions that could cause Rapid Nutrition PLCs actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements. Rapid Nutrition PLC has in some cases identified forward-looking statements by using words such as “anticipates,” “believes,” “hopes,” “estimates,” “looks,” “expects,” “plans,” “intends,” “goal,” “potential,” “may,” “suggest,” and similar expressions. Rapid PLC undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.
This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning of article 652a or article 1156 of the Swiss Code of Obligations or a listing prospectus within the meaning of the listing rules of the SIX Swiss Exchange. The media release is in accordance with International Reporting Standard: Rule 12g3-2(b) under the Securities Exchange Act (‘Rule 12g3-2(b)’) permits non-U.S. companies with securities listed primarily on a Qualified Foreign Exchange to make publicly available to U.S investors in English the same information that is made publicly available in their home countries as an alternative to SEC reporting Exchange Act Rule 12g3-2(b).